T2 Biosystems (TTOO) Tops Q3 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
T2 Biosystems Reports 2015 Third Quarter Results
November 2, 2015 4:00 PM ESTLEXINGTON, Mass., Nov. 02, 2015 (GLOBE NEWSWIRE) -- T2 Biosystems (NASDAQ: TTOO) today reported operating highlights and financial results for the third quarter ended September 30, 2015. Recent operational highlights included:
During the third quarter, the Company signed contracts for the adoption of T2Candida® and the T2Dx® with nine new hospitals in the United States. This brought the total number of hospitals to 19 as of September 30,... MoreT2 Biosystems Announces Leading Hospitals Adopting T2Candida for Sepsis Detection
October 29, 2015 6:30 AM EDTLEXINGTON, Mass., Oct. 29, 2015 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a company developing innovative diagnostic products to improve patient health, today announced that Rhode Island Hospital, the principal teaching hospital of The Warren Alpert Medical School of Brown University, the University of Alabama at Birmingham Hospital and The Statens Serum Institut in Denmark are among the first adopters of its... More
T2 Biosystems Announces Leading Hospitals Adopting T2Candida for Sepsis Detection
October 29, 2015 6:30 AM EDTLEXINGTON, Mass., Oct. 29, 2015 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a company developing innovative diagnostic products to improve patient health, today announced that Rhode Island Hospital, the principal teaching hospital of The Warren Alpert Medical School of Brown University, the University of Alabama at Birmingham Hospital and The Statens Serum Institut in Denmark are among the first adopters of its... More



